Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 18Sarcoma 2Genitourinary 2Other solid neoplasm 1

Conditions

Refractory Solid Tumors 1

Interventions

pembrolizumab 30Injections 26Pemetrexed 15Interviews as Topic 15tislelizumab 13Specimen Handling 13Carboplatin 13Cisplatin 12Nivolumab 11atezolizumab 10Practice Guidelines as Topic 9Educational Status 9Cyclophosphamide 9Bevacizumab 9Standard of Care 8Oxaliplatin 8Fluorouracil 8fludarabine 7Methods 7Early Intervention, Educational 7Docetaxel 7Cetuximab 7Capecitabine 7toripalimab 6sotorasib 6Platinum 6Paclitaxel 6Leucovorin 6Ipilimumab 6Gemcitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
eribulin × Other solid neoplasm × 90 days × Clear all
NCT06006273 2026-05-20

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
48 enrolled
Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡